...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>European journal of clinical pharmacology >Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country.
【24h】

Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country.

机译：公共药品采购：从转型国家的教学医院的药品招标中获得的经验教训。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

INTRODUCTION: There are scarce descriptions of hospital drug procurement in the primary literature. The aim of this study was to analyse the drug tender led by a clinical pharmacologist in a 1200-bed university hospital in Serbia, a developing country in socio-economic transition, and to give recommendations for future steps in hospital drug policy. PROCEDURE AND OUTCOMES: Drug tendering was conducted according to the public procurement law from January to April 2003. Analysis included the method of defined daily doses and anatomical therapeutic chemical classification, as well as minimal tender prices, free market prices, essential drugs and domestic and foreign manufacturers. The drug tender list consisted of 548 products, 1,315,501 pharmaceutical units and 312 drug entities, among which 164 were essential. For purchasing purposes, 479 drug formulations were selected, costing approximately 1.4 million Euros (approximately 10% of hospital budget). Three-quarters of the expenditure consisted of antimicrobials (29.1%), cytotoxics (28.8%) and intravenous infusions (17.7%). The top 20 drugs consumed 62.2% of the total drug expenditure. Competition for the most expensive and/or most used drugs was the key for financial success of applicants, even when they offered a limited number of drugs. The tender achieved 4.6% and 17.2% cost savings in comparison with minimal tender price and free-market price, respectively. The tender did not provide a fair balance between domestic and foreign manufacturers. CONCLUSION: The drug tender is resource-consuming, laborious, and risky job. Aggregation of individual tenders, on a national level and/or regional ones, is probably the best choice for hospitals in transition countries at this time.
机译：简介：在主要文献中很少有医院药品采购的描述。这项研究的目的是分析在社会经济转型的发展中国家塞尔维亚的一家拥有1200张床的大学医院中由临床药理学家领导的药物招标，并为医院药物政策的未来步骤提供建议。程序和结果：药品招标是根据公共采购法于2003年1月至2003年4月进行的。分析包括确定每日剂量的方法和解剖化学疗法的分类，以及最低招标价格，自由市场价格，基本药物以及国内和国外的价格。国外厂商。药品招标清单包括548种产品，1,315,501个药品单位和312个药品实体，其中164个是必不可少的。出于购买目的，选择了479种药物制剂，费用约为140万欧元（约占医院预算的10％）。支出的四分之三包括抗菌药物（29.1％），细胞毒素（28.8％）和静脉输液（17.7％）。前20种药物消耗了总药物支出的62.2％。即使申请人提供的药品数量有限，最昂贵和/或使用最多的药物的竞争也是申请人取得财务成功的关键。与最低投标价和自由市场价格相比，该投标分别节省了4.6％和17.2％的成本。招标没有在国内外制造商之间提供公平的平衡。结论：药品招标是耗资源，费力且有风险的工作。目前，在国家和/或地区进行单个投标的汇总可能是转型国家医院的最佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号